Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Research Communications in Chemical Pathology and Pharmacology
|
October 1, 1987
Serotonin efflux-inducing effects on human blood platelets by carbamoylpiperidine and nipecotoylpiperazine aggregation inhibitors
A Lasslo, E O Dillingham, R Gollamudi, et al.
Biochimica Et Biophysica Acta
|
April 25, 1984
Relationships between the chemical constitution of aggregation inhibitors and human blood platelet response profile
A Lasslo, R P Quintana, R W Johnson, et al.
Research Communications in Chemical Pathology and Pharmacology
|
February 1, 1990
The effect of carbamoylpiperidine and nipecotoylpiperazine analogs on ADP-stimulated human thrombocyte aggregation and platelet factor 3 availability
E O Dillingham, A Lasslo, R Gollamudi, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
February 1, 1990
Some novel inhibitors of platelet aggregation: acute toxicity in mice and its relationship to in vitro efficacy and toxicity. II. Nipecotoylaminoalkane and nipecotoylpiperazine congeners
W H Lawrence, A Lasslo, J E Turner, et al.
Biochimica Et Biophysica Acta
|
February 24, 1989
Relationships between chemical structure and inhibition of ADP-stimulated human thrombocyte release of serotonin and platelet factor 4
E O Dillingham, A Lasslo, G Carter-Burks, et al.
Arteriosclerosis (Dallas, Tex.)
|
May 1, 1990
Inhibition of thrombus formation in vivo by novel antiplatelet agent
U M Marzec, A B Kelly, S R Hanson, et al.
Biochimica Et Biophysica Acta
|
August 7, 1989
Relationships between chemical structure and inhibition of epinephrine-induced human blood platelet aggregation
J Petrusewicz, A Lasslo, G Carter-Burks, et al.
Medical Progress Through Technology
|
January 1, 1983
The influence of novel platelet aggregation inhibitors on human blood platelet clustering and retention effected by some polymer materials, in vitro
A Lasslo, R P Quintana, D Crisan, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
April 1, 1988
Some novel inhibitors of platelet aggregation: acute toxicity in mice and its relationship to in vitro activity and toxicity
W H Lawrence, P A Tisdelle, J E Turner, et al.
Medical Progress Through Technology
|
January 1, 1986
Interrelationships between the chemical structure of synthetic entities, their platelet aggregation inhibitory potency and their cellular toxicity, based on in vitro experiments
A Lasslo, E O Dillingham, J C McCastlain, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Research Communications in Chemical Pathology and Pharmacology
|
October 1, 1987
Serotonin efflux-inducing effects on human blood platelets by carbamoylpiperidine and nipecotoylpiperazine aggregation inhibitors
A Lasslo, E O Dillingham, R Gollamudi, et al.
Biochimica Et Biophysica Acta
|
April 25, 1984
Relationships between the chemical constitution of aggregation inhibitors and human blood platelet response profile
A Lasslo, R P Quintana, R W Johnson, et al.
Research Communications in Chemical Pathology and Pharmacology
|
February 1, 1990
The effect of carbamoylpiperidine and nipecotoylpiperazine analogs on ADP-stimulated human thrombocyte aggregation and platelet factor 3 availability
E O Dillingham, A Lasslo, R Gollamudi, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
February 1, 1990
Some novel inhibitors of platelet aggregation: acute toxicity in mice and its relationship to in vitro efficacy and toxicity. II. Nipecotoylaminoalkane and nipecotoylpiperazine congeners
W H Lawrence, A Lasslo, J E Turner, et al.
Biochimica Et Biophysica Acta
|
February 24, 1989
Relationships between chemical structure and inhibition of ADP-stimulated human thrombocyte release of serotonin and platelet factor 4
E O Dillingham, A Lasslo, G Carter-Burks, et al.
Arteriosclerosis (Dallas, Tex.)
|
May 1, 1990
Inhibition of thrombus formation in vivo by novel antiplatelet agent
U M Marzec, A B Kelly, S R Hanson, et al.
Biochimica Et Biophysica Acta
|
August 7, 1989
Relationships between chemical structure and inhibition of epinephrine-induced human blood platelet aggregation
J Petrusewicz, A Lasslo, G Carter-Burks, et al.
Medical Progress Through Technology
|
January 1, 1983
The influence of novel platelet aggregation inhibitors on human blood platelet clustering and retention effected by some polymer materials, in vitro
A Lasslo, R P Quintana, D Crisan, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
April 1, 1988
Some novel inhibitors of platelet aggregation: acute toxicity in mice and its relationship to in vitro activity and toxicity
W H Lawrence, P A Tisdelle, J E Turner, et al.
Medical Progress Through Technology
|
January 1, 1986
Interrelationships between the chemical structure of synthetic entities, their platelet aggregation inhibitory potency and their cellular toxicity, based on in vitro experiments
A Lasslo, E O Dillingham, J C McCastlain, et al.
Page
of 2